ROVATIN 20 TAB is a high-potency lipid-lowering pharmaceutical formulation developed by Bluepill Express. It contains Rosuvastatin Calcium equivalent to 20 mg of Rosuvastatin, one of the most effective statins in modern cardiovascular medicine. Rosuvastatin belongs to the HMG-CoA reductase inhibitor class of drugs, which work by blocking the enzyme responsible for cholesterol production in the liver, resulting in decreased levels of low-density lipoprotein (LDL), total cholesterol, and triglycerides, while simultaneously increasing levels of high-density lipoprotein (HDL) or "good" cholesterol.

ROVATIN 20 TAB is indicated for the treatment of primary hyperlipidemia, mixed dyslipidemia, and for the prevention of cardiovascular events in patients with existing risk factors such as diabetes, hypertension, or a family history of heart disease. It is also used in patients with homozygous familial hypercholesterolemia and atherosclerosis to slow the progression of plaque buildup in arterial walls. The 20 mg strength is often prescribed for patients needing intensive LDL reduction, especially when dietary and lifestyle interventions alone are insufficient.

The therapeutic effectiveness of ROVATIN 20 TAB is complemented by its once-daily oral dosing, which enhances patient compliance and long-term management of cardiovascular health. Clinical trials have demonstrated its efficacy in reducing LDL-C by up to 55% and triglycerides by 20-40%, depending on individual response and therapy duration. The medication is typically well tolerated, though some patients may experience mild side effects such as myalgia, fatigue, or elevated liver enzymes. Bluepill Express ensures safety through rigorous batch testing and full pharmacovigilance tracking.

Bluepill Express manufactures ROVATIN 20 TAB in a GMP and ISO 9001:2015 certified facility equipped with high-performance tablet compression, coating, and packaging systems. Each batch undergoes strict quality control checks including uniformity of dosage units, dissolution profiling, impurity analysis, and stability testing to ensure therapeutic efficacy and patient safety across various climatic zones. The tablets are available in moisture-resistant blister or alu-alu packs with multi-language labels for global export readiness.

The product complies with international pharmacopeial standards including USP and BP specifications and is supported by regulatory documentation such as Certificate of Analysis (COA), Manufacturing License, Stability Data, and COPP (Certificate of Pharmaceutical Product) where applicable. It is suitable for registration in ROW markets, with dossiers available in CTD format for ease of international submission.

ROVATIN 20 TAB is part of Bluepill Express’s expanding cardiovascular portfolio, offering high-demand generic formulations that meet both affordability and quality expectations. As a trusted third-party manufacturing partner, Bluepill Express offers full-scale OEM services including brand design, customized packaging, and door-to-door global logistics for clients across Latin America, Africa, the Middle East, Asia, and Europe.